2022/23: Glenelg (South Australia). E.coli, Bromodichloromethane

2022/2023 – Glenelg (South Australia) – E.coli

2/11/22: Glenelg (South Australia). E.coli 1 CFU/100mL

“E.coli

Thermotolerant coliforms are a sub-group of coliforms that are able to grow at 44.5 ± 0.2°C. E. coli is the most common thermotolerant coliform present in faeces and is regarded as the most specific indicator of recent faecal contamination because generally it is not capable of growth in the environment. In contrast, some other thermotolerant coliforms (including strains of Klebsiella, Citrobacter and Enterobacter) are able to grow in the environment and their presence is not necessarily related to faecal contamination. While tests for thermotolerant coliforms can be simpler than for E. coli, E. coli is considered a superior indicator for detecting faecal contamination…” ADWG

Glenelg  (South Australia) – Bromodichloromethane

2022/23: Glenelg (South Australia) Bromodichloromethane 79ug/L (max), 56.65ug/L (av.)

WHO Guideline level BDCM: 60ug/L (Australian Guideline for BDCM is included in the Trihalomethane (THM) combined total of BDCM, Chloroform, Dibromochloromethane and Bromoform. THM guideline is 250ug/L)

“Carcinogenicity : Bromodichloromethane is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.
Cancer Studies in Experimental Animals: Oral exposure to bromodichloromethane caused tumors at several different tissue sites in mice and rats. Administration of bromodichloromethane by stomach tube caused benign and malignant kidney tumors (tubular-cell adenoma and adenocarcinoma) in male mice and in rats of both sexes, benign and
malignant liver tumors (hepatocellular adenoma and carcinoma) in female mice, and benign and malignant colon tumors (adenomatous polyps and adenocarcinoma) in rats of both sexes (NTP 1987, ATSDR 1989, IARC 1991, 1999).